The estimated Net Worth of Anthony C. J. Fernando is at least $3.08 Million dollars as of 21 April 2024. Mr. Fernando owns over 271,739 units of Asensus Surgical Inc stock worth over $806,548 and over the last 9 years he sold ASXC stock worth over $99,090. In addition, he makes $2,176,430 as President, Chief Executive Officer, and Director at Asensus Surgical Inc.
Anthony has made over 15 trades of the Asensus Surgical Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 271,739 units of ASXC stock worth $94,538 on 21 April 2024.
The largest trade he's ever made was exercising 1,207,002 units of Asensus Surgical Inc stock on 3 February 2023 worth over $419,916. On average, Anthony trades about 209,090 units every 125 days since 2016. As of 21 April 2024 he still owns at least 2,318,332 units of Asensus Surgical Inc stock.
You can see the complete history of Mr. Fernando stock trades at the bottom of the page.
Anthony C.J. Fernando serves as President, Chief Executive Officer, Director of the Company. Mr. Fernando became our President and Chief Executive Officer and a member of the Board on November 8, 2019. Prior to his appointment as our President and Chief Executive Officer, Mr. Fernando previously served as our Chief Operating Officer since June 1, 2017, as our Chief Technology Officer, since January 2016, and as our Vice President, International Development from August 2015 through January 2016. Previously, Mr. Fernando served as Vice President, Innovation and Technology, International, of Stryker Singapore Pvt. Ltd, a global medical technology company, from October 2013 until July 2015. From August 2010 until October 2013, Mr. Fernando served as Director of Research and Development, greater Asia, for Becton Dickinson & Company, a global medical technology company engaged in the development, manufacture and sale of medical devices. From July 2007 until July 2010, Mr. Fernando served as the Director of Research and Development, Asia – Environmental Health, at Perkinelmer Singapore Pvt. Ltd. Until July 2015, Mr. Fernando also served as a director of Stryker India Private Limited and Stryker Global Technology Center (India). Mr. Fernando holds a BSc and MSc, Mechanical Engineering from the University of Nevada Las Vegas and an MBA, Finance & Strategy from the University of North Carolina at Chapel Hill. The Board believes that Mr. Fernando’s more than 20 years’ of operational experience in the medical device industry, at both privately held and multi-national companies, and his knowledge of the industry, coupled with his deep understanding of our technologies, product candidates, market and history make him an essential contributor to our Board.
As the President, Chief Executive Officer, and Director of Asensus Surgical Inc, the total compensation of Anthony Fernando at Asensus Surgical Inc is $2,176,430. There are no executives at Asensus Surgical Inc getting paid more.
Anthony Fernando is 48, he's been the President, Chief Executive Officer, and Director of Asensus Surgical Inc since 2019. There are 10 older and 1 younger executives at Asensus Surgical Inc. The oldest executive at Asensus Surgical Inc is William Kelley, 80, who is the Independent Director.
Anthony's mailing address filed with the SEC is C/O ASENSUS SURGICAL, INC., 1 TW ALEXANDER DRIVE, SUITE 160, DURHAM, NC, 27703.
Over the last 11 years, insiders at Asensus Surgical Inc have traded over $32,677,440 worth of Asensus Surgical Inc stock and bought 7,457,173 units worth $15,992,743 . The most active insiders traders include Jane Ph D Hsiao, Anthony C. J. Fernando, and William N Jr Starling. On average, Asensus Surgical Inc executives and independent directors trade stock every 46 days with the average trade being worth of $97,582. The most recent stock trade was executed by Rampertab Shameze on 21 April 2024, trading 81,521 units of ASXC stock currently worth $28,361.
asensus aps is a computer software company based out of 22a vallensbækvej, brondby, capital region of denmark, denmark.
Asensus Surgical Inc executives and other stock owners filed with the SEC include: